What is the retail price of a box of Eltrombopag?
Eltrombopag (Eltrombopag) is a thrombopoietic agent that is widely used to treat chronic immune thrombocytopenia (ITP), hepatitis C-related thrombocytopenia, severe aplastic anemia and other diseases. With the increase in clinical demand, eltrombopag has been approved for marketing in my country and has been included in the national medical insurance directory, providing patients with more accessible treatment options. After being included in medical insurance, the burden on patients is significantly reduced, especially during long-term medication.
Currently, the retail price of eltrombopag in the domestic market varies according to different specifications. Common specifications include 25mg and 50mg, usually sold in 14 capsules / boxes. Before the original drug is reimbursed, the domestic price is roughly between one or two thousand yuan to four or five thousand yuan. After medical insurance reimbursement, the personal burden may drop to half or even lower. It should be noted that different regions have different medical insurance policies and hospital procurement channels, and the price may be slightly different. It is recommended that patients consult the nearest hospital pharmacy to understand the actual selling price and reimbursement ratio.

In addition to the original drugs sold domestically, there are also more competitively priced versions in overseas markets. The original drug produced by Novartis in India is relatively affordable: 25mg×14 tablets are priced at 1700< 50mg These drugs are usually purchased through overseas medical channels, and their quality and efficacy are basically the same as those of domestic original drugs. However, they still need to be used under the guidance of a doctor, and attention should be paid to the formal and reliable sources of the drugs.
In addition, there are some generic versions of eltrombopag that are also widely concerned by patients, including the Lao version, the Indian version and the Bangladeshi version. These generic drugs are basically the same as the original drugs in terms of drug ingredients, dosage and mechanism of action, and the price is significantly lower, with each box usually selling for around a few hundred yuan. It is a cost-effective option for patients who take long-term medication or have insufficient medical insurance coverage. However, it should be noted that these generic drugs have not been registered and marketed in China and cannot be reimbursed by medical insurance. When purchasing, you must ensure that the channels are formal to ensure drug safety.
Reference materials:https://go.drugbank.com/drugs/DB06210
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)